Summit Therapeutics (SMMT) Q3 2024 Earnings Report
MX:SMMT Q3 2024 EPS Results
- Actual EPS
- -MXN 1.50
- Consensus EPS
- -MXN 1.26
- Beat/Miss
- Missed by -MXN 0.24
- One Year Ago EPS
- -MXN 0.56
MX:SMMT Q3 2024 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- MXN 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/30/2024
- Time
- Before Open
- Conference Call
- Wednesday, October 30, 2024
MX:SMMT Upcoming Earnings
Summit Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
MX:SMMT Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:SMMT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -5.30- | -5.83 | ― | ― |
| Jul 23, 2026 | 2026 (Q2) | -5.15-5.26 | -14.28 | 63.16% (+9.02) | |
| Apr 30, 2026 | 2026 (Q1) | -5.06-4.51 | -1.69 | -166.67% (-2.82) | |
| Feb 23, 2026 | 2025 (Q4) | -1.45-5.45 | -1.5 | -262.50% (-3.95) | |
| Oct 20, 2025 | 2025 (Q3) | -1.58-5.83 | -1.5 | -287.50% (-4.32) | |
| Aug 11, 2025 | 2025 (Q2) | -1.71-14.28 | -0.94 | -1420.00% (-13.34) | |
| May 01, 2025 | 2025 (Q1) | -1.75-1.69 | -1.13 | -50.00% (-0.56) | |
| Feb 24, 2025 | 2024 (Q4) | -1.54-1.50 | -0.94 | -60.00% (-0.56) | |
| Oct 30, 2024 | 2024 (Q3) | -1.26-1.50 | -0.56 | -166.67% (-0.94) | |
| Aug 06, 2024 | 2024 (Q2) | -1.17-0.94 | -0.39 | -138.10% (-0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
